In 1935, Clive McCay at Cornell published the first caloric restriction study, showing that rats fed 30-40% fewer calories than ad libitum controls lived up to 45% longer. In the nine decades since, the finding has been replicated in yeast, worms, flies, fish, mice, rats, dogs, and non-human primates.
The Wisconsin and NIA rhesus monkey studies -- running for over 30 years -- showed that calorically restricted monkeys had dramatically lower rates of diabetes, cancer, cardiovascular disease, and brain atrophy. The Wisconsin study showed a clear lifespan extension. The NIA study showed improved healthspan but not as clear a lifespan effect, likely due to differences in diet composition and control feeding protocols.
No other single intervention in the history of aging research has this breadth of evidence. Not exercise. Not any drug. Not any supplement. Caloric restriction is the gold standard against which everything else is measured.
The CALERIE (Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy) trial is the only randomized, controlled, long-term caloric restriction study in healthy, non-obese humans. Participants targeted a 25% caloric reduction but achieved closer to 12% over two years.
Even at that modest reduction, the results were striking. Participants showed a 2-3 year reduction in biological age as measured by the DunedinPACE epigenetic clock. They had reduced inflammation, improved insulin sensitivity, lower blood pressure, and better cholesterol profiles. Metabolic rate slowed significantly, suggesting the body was shifting into a conservation mode that mirrors what is seen in long-lived animal models.
But the study also revealed the cost. Participants lost significant lean muscle mass. Bone mineral density decreased. Thyroid hormones dropped. Libido declined. Some reported persistent feelings of cold and fatigue. At 12% restriction -- not even the 25% they were aiming for.
The CALERIE participants were motivated volunteers in a clinical setting with dietitian support, regular monitoring, and structured meal plans. They still could not hit 25% restriction. They averaged 12%.
In the real world, without any of that support? Sustained caloric restriction has an adherence rate that approaches zero over multi-year timeframes. Humans are not built to chronically undereat. Our hunger signals, social eating patterns, and psychological relationship with food make permanent restriction functionally impossible for all but the most disciplined individuals.
This is exactly why the caloric restriction mimetic drug industry exists. Rapamycin, metformin, resveratrol, spermidine -- they all attempt to activate the same cellular pathways (mTOR inhibition, AMPK activation, sirtuin signaling) that caloric restriction triggers, without the actual starving part.
You are probably not going to sustain 25% caloric restriction for decades. Almost nobody can. But you do not have to choose between severe restriction and doing nothing.
Moderate caloric awareness -- avoiding chronic overconsumption, eating nutrient-dense foods, not snacking mindlessly, occasional periods of reduced intake -- captures some of the metabolic benefits without the hormonal devastation. The CALERIE trial showed measurable biological age reversal at just 12% restriction. That is skipping dessert and one snack per day. It is not starvation. It is just... eating slightly less than you want to.
The truth about caloric restriction is that it works better than anything else in the lab and worse than almost anything else in real life. The gap between those two facts is where the entire future of longevity medicine will be built.
Science-backed health tips delivered every week.